ITGA7 Gene Myopathy due to Integrin 7A deficiency Genetic Test
Components: ITGA7 Gene Myopathy due to Integrin 7A deficiency Genetic Test
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for ITGA7 Gene Myopathy due to Integrin 7A deficiency NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ITGA7 Gene Myopathy due to Integrin 7A deficiency.
Test Details: ITGA7 gene myopathy is a rare genetic disorder caused by mutations in the ITGA7 gene. This gene provides instructions for making a protein called integrin alpha-7 (7). Integrins are a group of proteins that are involved in cell adhesion and signaling processes. Integrin alpha-7 is mainly found in skeletal and cardiac muscle cells, where it plays a crucial role in maintaining the structural integrity and function of these muscles. Mutations in the ITGA7 gene can lead to a deficiency or dysfunction of integrin alpha-7, resulting in muscle weakness and wasting. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. It allows for the identification of mutations or variations in the DNA sequence of specific genes, including the ITGA7 gene. NGS genetic testing for ITGA7 gene myopathy can help confirm a diagnosis and identify the specific genetic mutation causing the condition. This information can be important for understanding the underlying cause of the disease, predicting disease progression, and guiding treatment decisions. If you suspect that you or someone you know may have ITGA7 gene myopathy, it is recommended to consult with a healthcare professional or a genetic counselor who can provide more information about the testing process and help interpret the results.
Test Name | ITGA7 Gene Myopathy due to Integrin 7A deficiency Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for ITGA7 Gene Myopathy due to Integrin 7A deficiency NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ITGA7 Gene Myopathy due to Integrin 7A deficiency |
Test Details |
ITGA7 gene myopathy is a rare genetic disorder caused by mutations in the ITGA7 gene. This gene provides instructions for making a protein called integrin alpha-7 (7). Integrins are a group of proteins that are involved in cell adhesion and signaling processes. Integrin alpha-7 is mainly found in skeletal and cardiac muscle cells, where it plays a crucial role in maintaining the structural integrity and function of these muscles. Mutations in the ITGA7 gene can lead to a deficiency or dysfunction of integrin alpha-7, resulting in muscle weakness and wasting. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. It allows for the identification of mutations or variations in the DNA sequence of specific genes, including the ITGA7 gene. NGS genetic testing for ITGA7 gene myopathy can help confirm a diagnosis and identify the specific genetic mutation causing the condition. This information can be important for understanding the underlying cause of the disease, predicting disease progression, and guiding treatment decisions. If you suspect that you or someone you know may have ITGA7 gene myopathy, it is recommended to consult with a healthcare professional or a genetic counselor who can provide more information about the testing process and help interpret the results. |